Voyager Therapeutics names Toby Ferguson as Chief Medical Officer

Voyager Therapeutics, Inc.

Employment starts March 25, 2024; base salary $485,000, target bonus 40%.
Granted inducement option for 210k shares and RSU for 105k shares, both time-vesting.
Dr. Ferguson previously VP, Head of Neuromuscular Development at Biogen (2013-2024).
Severance provides 12 months base salary and pro-rata bonus if terminated without cause or for good reason within 12 months post sale event.
At-will employment; standard non-compete and confidentiality obligations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.